DD241748A5 - Reinigung biologischen materials - Google Patents

Reinigung biologischen materials Download PDF

Info

Publication number
DD241748A5
DD241748A5 DD85276680A DD27668085A DD241748A5 DD 241748 A5 DD241748 A5 DD 241748A5 DD 85276680 A DD85276680 A DD 85276680A DD 27668085 A DD27668085 A DD 27668085A DD 241748 A5 DD241748 A5 DD 241748A5
Authority
DD
German Democratic Republic
Prior art keywords
product
contaminants
lps
humulin
charge
Prior art date
Application number
DD85276680A
Other languages
German (de)
English (en)
Inventor
Stefan Svenson
Original Assignee
Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kk filed Critical Kk
Publication of DD241748A5 publication Critical patent/DD241748A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/42Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
    • B01D61/44Ion-selective electrodialysis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/04Specific process operations in the feed stream; Feed pretreatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD85276680A 1984-05-28 1985-05-24 Reinigung biologischen materials DD241748A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8402861A SE8402861L (sv) 1984-05-28 1984-05-28 Rening av biologiskt material

Publications (1)

Publication Number Publication Date
DD241748A5 true DD241748A5 (de) 1986-12-24

Family

ID=20356050

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85276680A DD241748A5 (de) 1984-05-28 1985-05-24 Reinigung biologischen materials

Country Status (20)

Country Link
US (1) US4746647A (sv)
EP (1) EP0185700A1 (sv)
JP (1) JPS61502378A (sv)
KR (1) KR860700135A (sv)
AU (1) AU4435885A (sv)
BR (1) BR8506758A (sv)
CS (1) CS257789B2 (sv)
DD (1) DD241748A5 (sv)
DK (1) DK39786A (sv)
ES (3) ES8609474A1 (sv)
FI (1) FI860316A (sv)
HU (1) HUT39774A (sv)
IL (1) IL75258A0 (sv)
IN (1) IN162119B (sv)
NO (1) NO860295L (sv)
NZ (1) NZ212155A (sv)
PL (1) PL253664A1 (sv)
SE (1) SE8402861L (sv)
WO (1) WO1985005631A1 (sv)
ZA (1) ZA853918B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
DE3526096A1 (de) * 1985-07-22 1987-01-22 Basf Ag Verfahren zur reinigung von htnf
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
US4798886A (en) * 1986-03-24 1989-01-17 Takeda Chemical Industries, Ltd. Mutual separation of proteins
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
DE3724442A1 (de) * 1987-07-23 1989-02-02 Europ Lab Molekularbiolog Verfahren und vorrichtung zur reinigung von m-13-phagen-dna
US5147779A (en) * 1988-06-01 1992-09-15 Miles Inc. Method for evaluating immunogenicity
AUPP521298A0 (en) * 1998-08-12 1998-09-03 Life Therapeutics Limited Purification of fibrinogen
AUPP790898A0 (en) 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
AUPP790698A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Separation of microorganisms
US20050224355A1 (en) * 1999-12-23 2005-10-13 Brendon Conlan Removal of biological contaminants
AUPP971399A0 (en) 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
US7077942B1 (en) 1999-12-23 2006-07-18 Gradipore Limited Removal of biological contaminants
AUPQ691400A0 (en) * 2000-04-14 2000-05-11 Life Therapeutics Limited Separation of micromolecules
AUPQ697300A0 (en) * 2000-04-18 2000-05-11 Life Therapeutics Limited Separation apparatus
ATE449200T1 (de) 2000-04-18 2009-12-15 Gradipore Ltd Trennung und behandlung von proben durch elektrophorese
US6923896B2 (en) * 2000-09-22 2005-08-02 The Texas A&M University System Electrophoresis apparatus and method
JP2004510170A (ja) * 2000-10-06 2004-04-02 グラディポア リミテッド マルチポート型分離装置および方法
AUPR222300A0 (en) * 2000-12-21 2001-01-25 Life Therapeutics Limited Electrophoresis device and method
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
GB201204756D0 (en) * 2012-03-19 2012-05-02 Lewi Paulus J Triazines with suitable spacers for treatment and/or prevention of HIV infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
SE7804098L (sv) * 1977-04-20 1978-10-21 R & Z Vermoegensverw Gmbh Peptidkomplex fran dna-haltiga organismer
US4276140A (en) * 1980-01-10 1981-06-30 Ionics Inc. Electrodialysis apparatus and process for fractionating protein mixtures
US4322275A (en) * 1980-01-10 1982-03-30 Ionics Incorporated Fractionation of protein mixtures
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
US4426323A (en) * 1980-01-10 1984-01-17 Ionics, Incorporated Selected recovery of proteins from fermentation broths
US4351710A (en) * 1980-01-10 1982-09-28 Ionics, Incorporated Fractionation of protein mixtures
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst HBs抗原の精製方法
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The HBsAgの精製方法

Also Published As

Publication number Publication date
IL75258A0 (en) 1985-09-29
DK39786D0 (da) 1986-01-27
ES552518A0 (es) 1988-08-01
SE8402861L (sv) 1985-11-29
PL253664A1 (en) 1986-02-11
ZA853918B (en) 1986-01-29
WO1985005631A1 (en) 1985-12-19
FI860316A0 (fi) 1986-01-22
DK39786A (da) 1986-01-27
AU4435885A (en) 1985-12-31
NO860295L (no) 1986-01-28
KR860700135A (ko) 1986-03-31
CS257789B2 (en) 1988-06-15
ES8802583A1 (es) 1988-08-01
US4746647A (en) 1988-05-24
NZ212155A (en) 1988-10-28
IN162119B (sv) 1988-04-02
ES543512A0 (es) 1986-08-01
ES8802584A1 (es) 1988-08-01
ES8609474A1 (es) 1986-08-01
ES552519A0 (es) 1988-08-01
FI860316A (fi) 1986-01-22
HUT39774A (en) 1986-10-29
BR8506758A (pt) 1986-09-23
CS368485A2 (en) 1987-11-12
EP0185700A1 (en) 1986-07-02
SE8402861D0 (sv) 1984-05-28
JPS61502378A (ja) 1986-10-23

Similar Documents

Publication Publication Date Title
DD241748A5 (de) Reinigung biologischen materials
EP0004940B1 (de) Verfahren zur radioimmunologischen Bestimmung von Prokollagen (Typ III) und Prokollagen-Peptid (Typ III), zur Herstellung von für das Verfahren geeignetem Prokollagen-Peptid (Typ III) und zur Herstellung von Anti-Prokollagen-Peptid (Typ III)-Serum
EP0143209B1 (de) Verfahren zur immunologischen Bestimmung von extrazellulären Matrixproteinen in Körperflüssigkeiten, unter Verwendung monovalenter Antikörperfragmente
DD148235A5 (de) Verfahren zur herstellung eines ausgewaehlten proteins
DE2925565A1 (de) Inkubations-doppelplatzimmunonachweisverfahren und mittel zur durchfuehrung des verfahrens
EP0021152A1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
DE3342870A1 (de) Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen
DE2720704A1 (de) Neues glycoprotein und verfahren zu dessen herstellung
DE2711773A1 (de) Verfahren zur reinigung und isolierung von hepatitisvirus zur herstellung eines impfstoffes
DE3939706C1 (sv)
DE2512975A1 (de) Polypeptid mit thymischer wirksamkeit
EP0014756A1 (de) Plazentaspezifisches Gewebsprotein PP10 und Verfahren zu seiner Anreicherung
EP0547059B1 (de) Pankreas-elastase-1-spezifischer antikörper, ein verfahren zu seiner gewinnung und ein testkit der solche antikörper enthält
EP1478662B1 (de) Verfahren zur herstellung von hypoallergenem birkenpollenhauptallergen rbet v 1
EP0025508B1 (de) Verfahren zur Herstellung der dritten Komponente des Komplements aus menschlichem Blutplasma
DE2732587A1 (de) Polypeptid mit thymischer wirksamkeit
DE3235516A1 (de) Verfahren der festphase-enzymimmunanalyse
DE4008546A1 (de) Osteocalcin-spezifischer monoclonaler antikoerper
DE3708198A1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
EP0420043B2 (de) Antikörper gegen hochkonservierte Aminosäuresequenzen von immunogenen Substanzen, Verfahren zur Herstellung dieser Antikörper, sowie deren Verwendung in Immunoassays
EP0133551A2 (de) Monoklonaler Antikörper, der eine Struktur erkennt die dem Human-Interleukin-2 (TCGF) und der leichten Kette "lambda" von Humanimmunglobulin gemeinsam ist, und Hybridoma-Zell-Linien, die diese monoklonalen Antikörper produzieren
DE19529026C2 (de) Monoklonale Antikörper gegen humanes Interleukin-10
EP0387850B1 (de) Monoklonale, gegen ECA gerichtete Antikörper und ihre Verwendung
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
DE2335102A1 (de) Proteide biologischen ursprungs, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee